Back to Search
VIVIAN FONSECA, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1346356037IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
12686R(LA)
Education
OTHER
Class of 1976
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.
PMID 23218892·Am J Med·2013
4-observational
Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences.
PMID 19542210·Diabetes Care·2009
8-other
Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.
PMID 19357717·Kidney Int·2009
6-review
Demystifying incretin therapy for type 2 diabetes. Introduction.
PMID 19580948·Eur J Intern Med·2009
8-other
Management of type 2 diabetes: oral agents, insulin, and injectables.
PMID 18358251·J Am Diet Assoc·2008
6-review
Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
PMID 18458145·Diabetes Care·2008
2-rct
Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
PMID 19410162·Clin Cornerstone·2008
8-other
Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus.
PMID 18401832·Horm Metab Res·2008
4-observational
Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
PMID 18357952·Clin Cornerstone·2007
6-review
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
PMID 17451422·Diabet Med·2007
4-observational
Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
PMID 17826042·Am J Med·2007
6-review
Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetes.
PMID 18159645·Clin Cornerstone·2007
6-review
Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.
PMID 17387446·Diabetologia·2007
2-rct
Commentary: Of HOPEs and DREAMs: the quest to prevent type 2 diabetes.
PMID 17062761·J Clin Endocrinol Metab·2006
8-other
Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease.
PMID 17028485·J Clin Hypertens (Greenwich)·2006
6-review
Commentary: the PROactive study--the glass is half full.
PMID 16303829·J Clin Endocrinol Metab·2006
8-other
Pharmacological treatment of the insulin resistance syndrome in people without diabetes.
PMID 18370733·Metab Syndr Relat Disord·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1430 TULANE AVE, SL 53
NEW ORLEANS, LA 70112 - Phone
- (504) 988-4026
Quick Facts
- NPI
- 1346356037
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile